Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors

Published:2009-06 Issue:2 Volume:2 Page:34-40
ISSN:1753-5174
Container-title:Archives of Drug Information
language:en
Short-container-title:

Author:

Rho Young Hee,Oeser Annette,Chung Cecilia P.,Milne Ginger L.,Stein C. Michael

Publisher

Wiley

Subject

Pharmacology (medical),Complementary and alternative medicine,General Pharmacology, Toxicology and Pharmaceutics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1753-5174.2009.00019.x/fullpdf

Reference29 articles.

1. Increased coronary-artery atherosclerosis in rheumatoid arthritis: Relationship to disease duration and cardiovascular risk factors;Chung;Arthritis Rheum,2005

2. Taking mortality in rheumatoid arthritis seriously-Predictive markers, socioeconomic status and comorbidity;Pincus;J Rheumatol,1986

3. Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study;Choi;Lancet,2002

4. Cardiovascular disease in patients with rheumatoid arthritis: Results from the QUEST-RA study;Naranjo;Arthritis Res Ther,2008

5. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial;Bresalier;N Engl J Med,2005

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rheumatoid arthritis, cardiometabolic comorbidities, and related conditions: need to take action;Frontiers in Medicine;2024-07-24

2. Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge;Biomedicines;2024-07-19

3. Dyslipidemia in rheumatoid arthritis: the possible mechanisms;Frontiers in Immunology;2023-10-25

4. Leflunomide alleviates obesity via activation of the TAK1‐AMPK pathway and induction of lipophagy;The FASEB Journal;2023-10-04

5. Evaluation of the role of hydroxychloroquine as a lipid profile improving and glucose adjusting drug in Egyptian females with inactive rheumatoid arthritis;Journal of The Arab Society for Medical Research;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3